1Gobin P,Lemaltre F,Marehand S. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chroma- tography - tandem mass spectrometry[J].Antimicrobial Agents and Chemotherapy,2010,(05):1941-1948.
2Bergen P J,Li J,Rayner C R. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa[J].Antimicrobial Agents and Chemotherapy,2006,(06):1953-1958.
3Falagas M E,Kasiakou S K. Colistin:The revival of polymyxins for the management of multidrug - resistant gram - negative bacterial infections[J].Clinical Infectious Diseases,2005,(09):1333-1341.
4Falagas M E,Kasiakou S K,Tsiodras S. The use of intra venous and aerosolized polymyxins for the treatment of infections in critically ill patients:A review of the recent literature[J].Clinical Medicine and Research,2006,(02):138-146.
5Nation R L,Li J. Colistin in the 21st[J].Century Curr Opin Infect Dis,2009,(06):535-543.
6Lim L M,Ly N,Anderson D. Resurgence of colistin:A review of resistance,toxicity,pharmaeodynamics,and dosing[J].Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy,2010,(12):1279-1291.
7Li J,Roger L N,John D T. Colistin :The re - emerging antibiotic for multidrug - resistant gram - negative bacterial infec- tions[J].Lancet Infectious Diseases,2006.589-601.
8陈杖榴.兽医药理学[M]北京:中国农业出版社,2002.
9Koch - Weser J,Sidel V W,Federman E B. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy[J].Annals of Internal Medicine,1970,(06):857-868.
10Fekety F R Jr,Norman P S,Cluff L E. The treatment of gram - negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty - eight patients[J].Annals of Internal Medicine,1962.214-229.
